These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37407037)

  • 1. SARS-CoV-2 self-testing in Peru: a cross-sectional survey of values and attitudes of the general population.
    Martínez-Pérez GZ; Shilton S; Mallma Salazar PS; Pflucker Oses P; Torres-Slimming PA; Batheja D; Banerji A; Mallery A; Ivanova Reipold E; Carcamo C
    BMJ Open; 2023 Jul; 13(7):e068980. PubMed ID: 37407037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Values and preferences of the general population in Indonesia in relation to rapid COVID-19 antigen self-tests: A cross-sectional survey.
    Thomas C; Shilton S; Thomas C; Batheja D; Goel S; Mone Iye C; Ivanova E; Martínez-Pérez GZ
    Trop Med Int Health; 2022 May; 27(5):522-536. PubMed ID: 35332616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-testing for SARS-CoV-2 in São Paulo, Brazil: results of a population-based values and attitudes survey.
    Martínez-Pérez GZ; Shilton S; Saruê M; Cesario H; Banerji A; Batheja D; Cunha JP; Baptista R; Schirmer J; Ivanova Reipold E; Machado Dias A
    BMC Infect Dis; 2022 Sep; 22(1):720. PubMed ID: 36056299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. People's willingness to use COVID-19 self-testing in Nigeria: a cross-sectional survey.
    Folayan M; Shilton S; Undelikwo V; Alaba O; Amusan R; Ibrahim M; Ogbozor PA; Mojisola O; Batheja D; Banerji A; Ivanova Reipold E; Martínez-Pérez GZ
    BMJ Open; 2023 Jan; 13(1):e063323. PubMed ID: 36717135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are Kenyans Likely to Use COVID-19 Self-Testing Kits? Results From a Cross-Sectional Survey.
    Manguro G; Shilton S; Omenda S; Owira P; Batheja D; Banerji A; Chabeda SV; Temmerman M; Jako W; Ndungu J; Luchters S; Ivanova Reipold E; Martínez-Pérez GZ
    Int J Public Health; 2022; 67():1604918. PubMed ID: 36090834
    [No Abstract]   [Full Text] [Related]  

  • 7. Rapid SARS-CoV-2 Antigen Detection Self-Tests to Increase COVID-19 Case Detection in Peru: Qualitative Study.
    Torres-Slimming PA; Carcamo C; Martínez-Pérez GZ; Mallma P; Pflucker C; Shilton S
    JMIR Form Res; 2023 Mar; 7():e43183. PubMed ID: 36867689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High SARS-CoV-2 Seroprevalence in Rural Peru, 2021: a Cross-Sectional Population-Based Study.
    Moreira-Soto A; Pachamora Diaz JM; González-Auza L; Merino Merino XJ; Schwalb A; Drosten C; Gotuzzo E; Talledo M; Arévalo Ramirez H; Peralta Delgado R; Bocanegra Vargas S; Drexler JF
    mSphere; 2021 Dec; 6(6):e0068521. PubMed ID: 34817236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 self-testing in Nigeria: Stakeholders' opinions and perspectives on its value for case detection.
    Undelikwo VA; Shilton S; Folayan MO; Alaba O; Reipold EI; Martínez-Pérez GZ
    PLoS One; 2023; 18(4):e0282570. PubMed ID: 37053243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating tuberculosis and COVID-19 molecular testing in Lima, Peru: a cross-sectional, diagnostic accuracy study.
    MacLean EL; Villa-Castillo L; Espinoza-Lopez P; Caceres T; Sulis G; Kohli M; Pai M; Ugarte-Gil C
    Lancet Microbe; 2023 Jun; 4(6):e452-e460. PubMed ID: 37068500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination coverage among COVID-19 prevention and control management teams at primary healthcare facilities in China and their attitudes towards COVID-19 vaccine: a cross-sectional online survey.
    Yan YY; Wang HT; Fan TY; Sun XJ; Du ZH; Sun XM
    BMJ Open; 2022 Apr; 12(4):e056345. PubMed ID: 35393315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The validity of self-reported SARS-CoV-2 results among postpartum respondents.
    McCarthy K; Maru S; Nowlin S; Ram P; Glazer KB; Janevic T
    Paediatr Perinat Epidemiol; 2022 Jul; 36(4):518-524. PubMed ID: 35257392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial.
    Garcia PJ; Mundaca H; Ugarte-Gil C; Leon P; Malaga G; Chaccour C; Carcamo CP
    Trials; 2021 Apr; 22(1):262. PubMed ID: 33836826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adequacy of Serial Self-performed SARS-CoV-2 Rapid Antigen Detection Testing for Longitudinal Mass Screening in the Workplace.
    Papenburg J; Campbell JR; Caya C; Dion C; Corsini R; Cheng MP; Menzies D; Yansouni CP
    JAMA Netw Open; 2022 May; 5(5):e2210559. PubMed ID: 35522284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceived Effectiveness, Safety, and Attitudes Toward the Use of Nucleic Tests of SARS-CoV-2 Among Clinicians and General Public in China.
    Lan R; Sujanto R; Lu K; He Z; Zhang CJP; Ming WK
    Front Public Health; 2020; 8():599862. PubMed ID: 33392138
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-19 self-testing using antigen rapid diagnostic tests: Feasibility evaluation among health-care workers and general population in Malawi.
    Mukoka M; Sibanda E; Watadzaushe C; Kumwenda M; Abok F; Corbett EL; Ivanova E; Choko AT
    PLoS One; 2023; 18(7):e0289291. PubMed ID: 37506068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Performance Assessment of Saliva RT-PCR and Nasopharyngeal Antigen for the Detection of SARS-CoV-2 in Peru.
    Calderón RI; Jhaveri TA; Tovar MA; Palomino JS; Barreda NN; Sanabria OM; Peinado J; Ramirez C; Llanos Zavalaga LF; Valderrama G; Franke MF; Mitnick CD; Lecca L; Velásquez GE
    Microbiol Spectr; 2022 Aug; 10(4):e0086122. PubMed ID: 35867471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass Screening of SARS-CoV-2 With Rapid Antigen Tests in a Receding Omicron Wave: Population-Based Survey for Epidemiologic Evaluation.
    Kwan TH; Wong NS; Chan CP; Yeoh EK; Wong SY; Lee SS
    JMIR Public Health Surveill; 2022 Nov; 8(11):e40175. PubMed ID: 36240027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine-hesitant individuals accumulate additional COVID-19 risk due to divergent perception and behaviors related to SARS-CoV-2 testing: a population-based, cross-sectional study.
    Wratil PR; Kotter K; Bischof ML; Hollerbach S; Apak E; Kalteis AL; Nayeli-Pflantz T; Kaderali L; Adorjan K; Keppler OT
    Infection; 2023 Aug; 51(4):909-919. PubMed ID: 36355269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Public knowledge of SARS-CoV-2 serological and viral lineage laboratory testing and result interpretation: A GENCOV study cross-sectional survey.
    Morgan G; Briollais L; Clausen M; Casalino S; Mighton C; Chowdhary S; Frangione E; Fung CYJ; Arnoldo S; Bearss E; Binnie A; Borgundvaag B; Dagher M; Devine L; Friedman SM; Khan Z; McGeer A; McLeod SL; Richardson D; Stern S; Taher A; Wong I; Zarei N; Bombard Y; Lerner-Ellis J; Taher J
    Clin Biochem; 2023 Aug; 118():110607. PubMed ID: 37406717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.